Results 21 to 30 of about 1,260,166 (238)
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins [PDF]
Frontiers in Immunology, 2021 Wilhelm Schwaeble +2 more
exaly +2 more sources
Components of the Lectin Pathway of Complement in Solid Tumour Cancers [PDF]
Cancers, 2022 Anna Świerzko, Maciej Cedzyński
exaly +2 more sources
Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality [PDF]
Frontiers in Immunology, 2021 Federica Defendi, Audrey le Gouellec
exaly +2 more sources
Lectin complement pathway and diabetes mellitus in the pathogenesis of membranous nephropathy [PDF]
Folia Medica, 2023 Introduction: Membranous nephropathy (MN) is a glomerulonephritis with growing incidence and its pathogenesis still remains unclear, despite discoveries of many new antigens.
Irina Y. Zdravkova +2 more
doaj +3 more sources
Mannose binding lectin defects and autoimmune diseases [PDF]
Records of Pharmaceutical & Biomedical Sciences, 2022 Complement system has a very important role in our defense against different pathogens and harmful immune complexes. The lectin pathway of complement system is activated by mannose binding lectin leading to complement cascade ending with the removal of ...
Marwa Azab +5 more
doaj +1 more source
Инфекция и иммунитет, 2022 The complement system is the most ancient components in the innate immunity, mainly functioning to primarily eliminate bacterial agents intravascularly.
Marina V. Smolnikova +1 more
doaj +1 more source
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab [PDF]
Immunobiology, 2020 Aurelio Sonzogni +2 more
exaly +2 more sources
Components of the Lectin Pathway of Complement in Haematologic Malignancies. [PDF]
Cancers (Basel), 2020 The complement system is activated cascadically via three distinct major routes: classical pathway (CP), alternative pathway (AP) or lectin pathway (LP).
Cedzyński M, Świerzko AS.
europepmc +2 more sources
Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis
Nefrología (English Edition), 2017 Background: Membranoproliferative glomerulonephritis (MPGN type I, II and III) was reclassified in 2013 as MPGN and C3 glomerulopathy (C3G) based on the complement system activation mechanism.
Nirupama Gupta +3 more
doaj +3 more sources